Xencor



Ebit Endring Dato
AbbVie USD 5.65B 407M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amgen USD 3.6B 434M 2025-03
Arrowhead Research USD -161412000 791K 2024-12
AstraZeneca USD 4.8B 604M 2025-03
Biogen USD 582.8M 61.3M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Cytokinetics USD -155631000 16.59M 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
J&J USD 7.39B 2.04B 2025-03
MacroGenics USD -52837000 107.35M 2024-12
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Roche Holding CHF 11.29B 2.68B 2024-06
Xencor USD -13178000 47.7M 2024-12



Xencor - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.